Acting Solicitor General Neal Katyal has requested an April 4, 2011, oral argument date in a case before the Federal Circuit Court of Appeals asking whether and to what extent genetic discoveries may be patented. The Ass’n for Molecular Pathology v. U.S. Pat. & Trademark Office (Myriad Genetics, Inc.), No. 2010-1406 (Fed. Cir.). Katyal is apparently also planning to argue the government’s position in global warming and health-care reform cases pending before the U.S. Supreme Court and Fourth Circuit, respectively, which arguments are scheduled in April and May. Additional information about Myriad appears in Issue 2 of this Bulletin. The U.S. Department of Justice contends that genomic DNA isolated from the human body, without further alteration or manipulation, should not be eligible for patents.